$131.82
0.87% yesterday
Nasdaq, Jun 27, 10:15 pm CET
ISIN
US44930G1076
Symbol
ICUI

ICU Medical, Inc. Stock price

$131.82
+1.38 1.06% 1M
-22.64 14.66% 6M
-23.35 15.05% YTD
+13.10 11.03% 1Y
-37.58 22.18% 3Y
-48.34 26.83% 5Y
+37.03 39.07% 10Y
+101.13 329.52% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
+1.14 0.87%
ISIN
US44930G1076
Symbol
ICUI
Sector

Key metrics

Basic
Market capitalization
$3.2b
Enterprise Value
$4.5b
Net debt
$1.3b
Cash
$289.7m
Shares outstanding
24.6m
Valuation (TTM | estimate)
P/E
negative | 19.47
P/S
1.34 | 1.44
EV/Sales
1.86 | 2.00
EV/FCF
37.03
P/B
1.63
Financial Health
Equity Ratio
46.75%
Return on Equity
-5.99%
ROCE
3.49%
ROIC
8.14%
Debt/Equity
0.77
Financials (TTM | estimate)
Revenue
$2.4b | $2.2b
EBITDA
$128.0m | $394.2m
EBIT
$126.9m
Net Income
$-93.7m | $166.6m
Free Cash Flow
$121.4m
Growth (TTM | estimate)
Revenue
7.22% | -5.59%
EBITDA
153.88% | 279.19%
EBIT
157.49%
Net Income
-57.94% | 241.56%
Free Cash Flow
61.95%
Margin (TTM | estimate)
Gross
35.11%
EBITDA
5.29% | 17.53%
EBIT
5.25%
Net
-3.87% | 7.41%
Free Cash Flow
5.02%
More
EPS
$-3.83
FCF per Share
$4.93
Short interest
5.30%
Employees
15.00k
Rev per Employee
$160.00k
Show more

Is ICU Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

ICU Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a ICU Medical, Inc. forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a ICU Medical, Inc. forecast:

Buy
82%
Hold
18%

Financial data from ICU Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,420 2,420
7% 7%
100%
- Direct Costs 1,570 1,570
3% 3%
65%
850 850
16% 16%
35%
- Selling and Administrative Expenses 637 637
4% 4%
26%
- Research and Development Expense 90 90
3% 3%
4%
128 128
154% 154%
5%
- Depreciation and Amortization 1.09 1.09
4% 4%
0%
EBIT (Operating Income) EBIT 127 127
157% 157%
5%
Net Profit -94 -94
58% 58%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about ICU Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICU Medical, Inc. Stock News

Neutral
Seeking Alpha
about 2 months ago
ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants John Mills – ICR, IR Vivek Jain – Chief Executive Officer and Chairman Brian Bonnell – Chief Financial Officer Conference Call Participants Jayson Bedford – Raymond James Brett Fishbin – KeyBanc Capital Markets Larry Solow – CJS Securities Michael Toomey – Jefferies Operator Good day, a...
Neutral
Accesswire
about 2 months ago
BOSTON, MA / ACCESS Newswire / May 8, 2025 / Block & Leviton is investigating ICU Medical, Inc. (Nasdaq:ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical, Inc. investment should contact the firm to learn more about how they might recover those losses.
Neutral
GlobeNewsWire
about 2 months ago
SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025.
More ICU Medical, Inc. News

Company Profile

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Head office United States
CEO Vivek Jain
Employees 15,000
Founded 1984
Website www.icumed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today